Allergan Aesthetics has announced the launch of BOTOX® Cosmetic (onabotulinumtoxinA) for treating masseter muscle prominence (MMP) in adults in China, marking a significant expansion of the product’s approved aesthetic applications in the world’s second-largest economy. The approval addresses a growing demand for non-surgical facial contouring procedures in the Chinese market, where jawline refinement has become an increasingly sought-after aesthetic treatment.
Masseter muscle prominence occurs when the masseter muscles—the primary chewing muscles located at the angle of the jaw—become enlarged or hypertrophied, creating a wider, more squared facial appearance. This condition can result from genetics, chronic teeth grinding (bruxism), or habitual jaw clenching. The new indication allows healthcare providers in China to use BOTOX® Cosmetic to temporarily reduce the size of these muscles, creating a slimmer, more contoured lower face profile.
The approval reflects broader aesthetic preferences in Asian markets, where a V-shaped or oval facial contour is often considered a beauty ideal. Unlike surgical jawline reduction procedures, BOTOX® treatment for MMP offers a non-invasive alternative with minimal downtime. The neurotoxin works by temporarily blocking nerve signals to the masseter muscles, causing them to relax and gradually decrease in size over several weeks following treatment.
China represents a critical growth market for aesthetic medicine companies, with the country’s medical aesthetics industry experiencing rapid expansion in recent years. The addition of MMP treatment to BOTOX® Cosmetic’s portfolio in China could potentially capture significant market share in the facial contouring segment, which has traditionally relied on surgical interventions or dermal fillers.
For patients considering this treatment, the approval means access to an established, FDA-recognized brand for masseter reduction. However, potential patients should consult qualified healthcare providers to determine if they are appropriate candidates and to understand the temporary nature of results, which typically require maintenance treatments every four to six months to sustain the slimming effect.